People with schizophrenia die 15‐20 years prematurely. Understanding mortality risk and
aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic …

Schizophrenia is a severe psychiatric disorder with high heritability. Consortia efforts and
technological advancements have led to a substantial increase in knowledge of the genetic …

Antipsychotics are effective in preventing relapses of schizophrenia, but it is generally
believed that their long‐term use is harmful for patients' physical well‐being. However, there …

An extensive literature regarding gender differences relevant to several aspects of
schizophrenia is nowadays available. It includes some robust findings as well as some …

Background Mental disorders are associated with premature mortality. There is increasing
research examining life expectancy and years-of-potential-life-lost (YPLL) to quantify the …

Importance Individuals with psychotic disorders have increased mortality, and recent
research suggests a marked increase shortly after diagnosis. Objective To use population …

Background People with schizophrenia have an increased risk of premature mortality
compared to the general population. We aimed to quantify which types of causes of death …

Objective To investigate the association of single‐and multimorbidity with mortality rates in
patients with schizophrenia compared to the general population. Method A nationwide …

Background Peripheral immune markers have previously been linked to a poor response to
antipsychotic medication and more severe negative symptoms at the onset of psychosis. The …

Background Schizophrenia is associated with a wide range of socioeconomic and health-
related problems, as well as 10–25 potential life-years lost. While lifestyle choices …